We report on a 30-year-old patient with advanced cerebellar degeneration due to SCA2. He presented with severe myoclonus, which was resistant to conventional therapy and dramatically improved after administration of 12–18 gm/die piracetam. Piracetam may be considered in the treatment of refractory myoclonus in spinocerebellar degenerations.
Suppression of myoclonus in SCA2 by piracetam / DE ROSA, Anna; Striano, P; Barbieri, Fabrizio; de Falco, A; Rinaldi, C; Tucci, T; Striano, Salvatore; Filla, Alessandro; DE MICHELE, Giuseppe. - In: MOVEMENT DISORDERS. - ISSN 0885-3185. - STAMPA. - 21:(2006), pp. 116-118. [10.1002/mds.20683]
Suppression of myoclonus in SCA2 by piracetam.
DE ROSA, ANNA;BARBIERI, FABRIZIO;STRIANO, SALVATORE;FILLA, ALESSANDRO;DE MICHELE, GIUSEPPE
2006
Abstract
We report on a 30-year-old patient with advanced cerebellar degeneration due to SCA2. He presented with severe myoclonus, which was resistant to conventional therapy and dramatically improved after administration of 12–18 gm/die piracetam. Piracetam may be considered in the treatment of refractory myoclonus in spinocerebellar degenerations.| File | Dimensione | Formato | |
|---|---|---|---|
|
Suppression of Myoclonus in SCA2 by Piracetam.pdf
accesso aperto
Tipologia:
Documento in Post-print
Licenza:
Dominio pubblico
Dimensione
52.18 kB
Formato
Adobe PDF
|
52.18 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
